Cardiac Science May Pursue Hostile Bid For Spacelabs Installed Monitor Base
This article was originally published in The Gray Sheet
Executive Summary
Spacelabs Medical's deferring of a decision on Cardiac Science, Inc.' s (CSI) second merger offer in two weeks could lead to a hostile takeover bid to acquire Spacelabs' installed base of about 65,000 hospital patient monitors.
You may also be interested in...
Instrumentarium Critical Care Presence To Blast Off From Spacelabs’ Base
Instrumentarium will gain an installed base of over 100,000 patient monitors worldwide through its $140 mil. cash acquisition of Spacelabs Medical and "more than triple" sales to the critical care market, the firm says
Instrumentarium Critical Care Presence To Blast Off From Spacelabs’ Base
Instrumentarium will gain an installed base of over 100,000 patient monitors worldwide through its $140 mil. cash acquisition of Spacelabs Medical and "more than triple" sales to the critical care market, the firm says
Respironics Investors Breathing Easy After Turnaround; Stock Up 25% In Nov.
An accelerating growth rate and positive news highlighted at Respironics' Nov. 16 annual shareholder meeting breathed new life into the company's stock price. The issue closed Nov. 30 at $24.56, up $4.93, or 25.1%, for the month.